Demo | РакФонд

Новости

Immunotherapy with genetically modified lymphocytes, such as CAR-T cells, is one of the most promising areas of modern basic and clinical oncology. A CAR-T cell is a T-lymphocyte in which a gene encoding a CAR (chimeric antigen receptor) has been introduced ex vivo. Simplifying the ...
Читать далее
Dear Friends and Colleagues! Today, on March 16, Professor Boris Afanasyev, member of the Foundation’s Scientific Advisory Board, Doctor of Medical Sciences, Honored Doctor of the Russian Federation, Director of the R.M. Gorbacheva Institute of Pediatric Oncology, Hematology, Oncology and Transplantology, founder of one of ...
Читать далее
A report on the results of the Foundation's operations in 2019 has been posted on our website. It contains the detailed description of supported research, events, financials, and our supporters. We thank our donors for the support of the Foundation, all team members, trustees, experts, ...
Читать далее
On February 4th, the World Cancer Day, the American Society of Clinical Oncology (ASCO) published the 15th annual report on the progress against cancer (Markham MJ, et al. J Clin Oncol 2020). Below is the summary of this report. Cancer is one of the biggest ...
Читать далее
Today, on World Cancer Day, the Foundation for Cancer Research Support opens applications submission to the competition of research projects in radiation therapy in oncology. The aim of this funding program is to provide funding and other means of support to the scientists and clinicians ...
Читать далее

Подписка на новости

Даю согласие на обработку своих персональных данных [текст Согласия]

Вы можете в любое время отказаться от рассылки новостей, направив запрос по электронной почте на адрес info@rakfond.org.

Наши партнеры